Dexcom Inc (DXCM) Stock Price, Quote & News

Company Profile

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with predi...

Industry: Medical Devices

Sector: Healthcare

Phone: 858 200 0200

Website: www.dexcom.com

Address:

6340 Sequence Drive, San Diego, United States

BriOnH Sep. 11 at 6:32 PM

$SANA $ELDN $DXCM $PODD $TNDM It appears it is safe to assume Endo Axiom's Smart Oral insulin is now in human(s). Please Jesus let this work. This will ineffably transform the lives for us T1D's. Sana with sc451 is still on the horizon with Ph 1/2 to begin this year, IMHO the best potential option. Tego + Cadaveric islets is here RIGHT NOW with 12 out of 12 people (functionally) cured. T1D your days are numbered bitch. https://www.sydney.edu.au/news-opinion/news/2026/09/10/oral-insulin-drug-achieves-a-critical-milestone--.html

1 · Reply

Chrissytina Sep. 11 at 6:05 PM

$DXCM WTF, Why??? I mean really!!! 😡

0 · Reply

JInvestTrade Sep. 10 at 11:46 AM

$SENS $DXCM $TNDM $PODD $ABT https://lnkd.in/p/eTiFrp-W

0 · Reply

BriOnH Sep. 4 at 5:32 PM

$SANA $ELDN $DXCM $PODD $TNDM Today is scheduled to be the first person ever dosed with Endo Axium Smart Oral Insulin. This could potentially radically change the lives for us T1D's, with even better stuff on the horizon. 🙏🏻🤞

3 · Reply

LQQKER_INSIDER Sep. 4 at 2:59 PM

$DXCM Out with $3,900 profit. 💋 Not too shabby for less than 48 hours. Shorted it first, then covered the short once I had my puts options purchased. Already l👀king to reenter puts on any gap ups.

0 · Reply

ckjamesst Sep. 3 at 2:40 PM

$DXCM one hour has nice hammer candle expecting g something big incoming towards downside

0 · Reply

ckjamesst Sep. 3 at 2:20 PM

$DXCM sell sell

0 · Reply

ckjamesst Sep. 3 at 2:14 PM

$DXCM insider selling you should sell

0 · Reply

ckjamesst Sep. 3 at 12:54 PM

$DXCM same pattern again and again…

0 · Reply

ckjamesst Sep. 3 at 12:46 PM

$DXCM it’s going to be volatile few months best time to get in puts

0 · Reply

Dexcom Appoints Glenn Boehnlein to Board of Directors

Sep 9, 2026, 8:00 AM EDT - 4 days ago

DexCom Transcript: Wells Fargo 21st Annual Healthcare Conference

Sep 7, 2026, 3:27 PM EDT - 6 days ago

Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Sep 3, 2026, 1:51 AM EDT - 10 days ago

Revisiting Stock Picks Dexcom, Bristol Myers Squibb, Quanta Services

BMY PWR

Sep 1, 2026, 8:30 AM EDT - 12 days ago

Dexcom Announces Upcoming Conference Presentation

Aug 20, 2026, 1:00 PM EDT - 24 days ago

The Big 3: PH, DXCM, UNP

PH UNP

2026-08-17T08:21:53.000Z - 27 days ago

DexCom price target raised to $105 from $88 at Citi

2026-08-04T13:21:04.000Z - 5 weeks ago

DexCom price target raised to $96 from $86 at Argus

2026-08-03T11:05:25.000Z - 5 weeks ago

DexCom price target raised to $90 from $82 at Canaccord

2026-07-31T12:56:52.000Z - 6 weeks ago

DexCom price target raised to $92 from $86 at Deutsche Bank

2026-07-31T12:36:49.000Z - 6 weeks ago

DexCom price target raised to $94 from $91 at Raymond James

2026-07-31T12:06:10.000Z - 6 weeks ago

DexCom price target raised to $90 from $80 at BTIG

2026-07-31T12:05:47.000Z - 6 weeks ago

DexCom price target raised to $82 from $77 at Benchmark

2026-07-31T11:38:20.000Z - 6 weeks ago

DexCom price target raised to $95 from $88 at Piper Sandler

2026-07-31T11:31:21.000Z - 6 weeks ago

DexCom price target raised to $95 from $90 at Mizuho

2026-07-31T11:26:07.000Z - 6 weeks ago

DexCom price target raised to $82 from $65 at JPMorgan

2026-07-31T11:20:53.000Z - 6 weeks ago

DexCom price target raised to $105 from $80 at Baird

2026-07-31T11:20:30.000Z - 6 weeks ago

DexCom price target raised to $95 from $90 at Stifel

2026-07-31T10:45:45.000Z - 6 weeks ago

DexCom price target raised to $88 from $84 at Citi

Jul 30, 2026, 4:32 PM EDT - 6 weeks ago

Dexcom raises annual revenue forecast on strong demand for glucose monitors

Jul 30, 2026, 4:30 PM EDT - 6 weeks ago

DexCom Earnings Call Transcript: Q2 2026

Jul 30, 2026, 4:30 PM EDT - 6 weeks ago

DexCom Slides: Q2 2026

Jul 30, 2026, 4:30 PM EDT - 6 weeks ago

DexCom Earnings release: Q2 2026

Jul 30, 2026, 4:30 PM EDT - 6 weeks ago

DexCom Quarterly report: Q2 2026

2026-07-30T20:17:35.000Z - 6 weeks ago

DexCom reports Q2 EPS 70c, consensus 61c

2026-07-30T20:17:18.000Z - 6 weeks ago

DexCom sees FY25 revenue $5.15B-$5.25B, consensus $5.22B

Jul 30, 2026, 4:02 PM EDT - 6 weeks ago

Dexcom Reports Second Quarter 2026 Financial Results

Jul 22, 2026, 5:15 PM EDT - 7 weeks ago

Dexcom Announced as First Participant Selected for FDA's TEMPO Digital Health Devices Pilot Program

Jul 13, 2026, 4:45 PM EDT - 2 months ago

Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes

Jul 9, 2026, 8:30 AM EDT - 2 months ago

Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time

Jun 23, 2026, 9:00 AM EDT - 2 months ago

Dexcom Further Advances Vision of Glucose Biosensing for All

Jun 18, 2026, 2:14 PM EDT - 2 months ago

Living Longer Is Big Business. These Stocks Will Benefit.

ABT GH HIMS PLNT

Jun 17, 2026, 12:30 PM EDT - 2 months ago

The Healthcare M&A Wave

ABT ALNY AMGN AMRX ANTX AZN BDX

Jun 12, 2026, 4:15 PM EDT - 3 months ago

FDA clears first over-the-counter glucose monitor for children

Jun 11, 2026, 6:08 AM EDT - 3 months ago

Pharmsource says it was unaware Dexcom sensors it bought were slated for destruction

Jun 6, 2026, 2:49 PM EDT - 3 months ago

Dexcom's glucose monitor use shows benefit in non-insulin diabetic patients in study

Jun 6, 2026, 2:45 PM EDT - 3 months ago

Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin

Jun 4, 2026, 9:00 AM EDT - 3 months ago

Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026

Jun 2, 2026, 9:30 AM EDT - 3 months ago

Dexcom Releases Customer Advisory Council Report, Outlining Ongoing Commitments to Enhancing Product Performance and User Experience

May 27, 2026, 9:07 AM EDT - 3 months ago

Signos grows foothold in weight-loss wave fueled by GLP-1s with its AI health data tracking

May 26, 2026, 10:47 AM EDT - 3 months ago

Dexcom warns patients as stolen glucose sensors hit the market

May 26, 2026, 9:30 AM EDT - 3 months ago

Dexcom Uncovers Theft of Scrapped Product, Notifies Potentially Impacted Users

May 18, 2026, 7:31 AM EDT - 3 months ago

Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany

May 14, 2026, 5:41 PM EDT - 4 months ago

Dexcom to appoint two directors, revamp board committee with Elliott

May 14, 2026, 4:15 PM EDT - 4 months ago

DexCom Transcript: Investor Day 2026

May 14, 2026, 4:15 PM EDT - 4 months ago

DexCom Slides: FY 2026

May 14, 2026, 4:02 PM EDT - 4 months ago

Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day

May 5, 2026, 8:30 AM EDT - 4 months ago

Dexcom to Host Investor Day on May 14, 2026

Apr 30, 2026, 4:52 PM EDT - 4 months ago

Dexcom reaffirms full-year forecast after topping quarterly estimates

Apr 30, 2026, 4:30 PM EDT - 4 months ago

DexCom Earnings Call Transcript: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 4 months ago

DexCom Earnings release: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 4 months ago

DexCom Slides: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 4 months ago

DexCom Quarterly report: Q1 2026

Apr 30, 2026, 4:02 PM EDT - 4 months ago

Dexcom Reports First Quarter 2026 Financial Results

Apr 30, 2026, 7:00 AM EDT - 4 months ago

DexCom Slides: Investor presentation

Apr 15, 2026, 8:00 AM EDT - 5 months ago

DexCom Proxy statement: Proxy filing

Apr 15, 2026, 8:00 AM EDT - 5 months ago

DexCom Proxy statement: Proxy filing

Apr 2, 2026, 8:30 AM EDT - 5 months ago

Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time

Mar 11, 2026, 2:00 AM EDT - 6 months ago

Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026

Mar 2, 2026, 1:05 PM EST - 6 months ago

DexCom Transcript: 47th Annual Raymond James Institutional Investor Conference

Feb 26, 2026, 4:15 PM EST - 6 months ago

Dexcom Appoints Rick Osterloh to Board of Directors

Feb 25, 2026, 8:00 PM EST - 6 months ago

HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Feb 19, 2026, 1:00 PM EST - 6 months ago

The Big 3: VZ, DXCM, AMAT

AMAT VZ

Feb 12, 2026, 4:43 PM EST - 7 months ago

Dexcom beats quarterly estimates on strong demand for glucose monitors

Feb 12, 2026, 4:30 PM EST - 7 months ago

DexCom Earnings Call Transcript: Q4 2025

Feb 12, 2026, 4:30 PM EST - 7 months ago

DexCom Annual report: Q4 2025

Feb 12, 2026, 4:30 PM EST - 7 months ago

DexCom Earnings release: Q4 2025

Feb 12, 2026, 4:30 PM EST - 7 months ago

DexCom Slides: Q4 2025

Feb 12, 2026, 4:03 PM EST - 7 months ago

Dexcom Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Feb 12, 2026, 7:00 AM EST - 7 months ago

DexCom Slides: Investor presentation

Feb 4, 2026, 8:30 AM EST - 7 months ago

Stelo Adds Enhanced Smart Meal Logging Features as Dexcom Continues to Transform Personal Glucose Management

Jan 27, 2026, 8:30 AM EST - 7 months ago

Dexcom Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call for February 12, 2026 at 4:30 p.m. Eastern Time.

Jan 15, 2026, 12:06 PM EST - 8 months ago

Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Jan 13, 2026, 5:24 PM EST - 8 months ago

Watch CNBC's exclusive interview with Dexcom CEO Jake Leach

Jan 12, 2026, 10:30 AM EST - 8 months ago

DexCom Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 10:30 AM EST - 8 months ago

DexCom Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 7:30 AM EST - 8 months ago

Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook

Jan 7, 2026, 9:00 AM EST - 8 months ago

Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer

BriOnH Sep. 11 at 6:32 PM

1 · Reply

Chrissytina Sep. 11 at 6:05 PM

$DXCM WTF, Why??? I mean really!!! 😡

0 · Reply

JInvestTrade Sep. 10 at 11:46 AM

$SENS $DXCM $TNDM $PODD $ABT https://lnkd.in/p/eTiFrp-W

0 · Reply

BriOnH Sep. 4 at 5:32 PM

3 · Reply

LQQKER_INSIDER Sep. 4 at 2:59 PM

0 · Reply

ckjamesst Sep. 3 at 2:40 PM

$DXCM one hour has nice hammer candle expecting g something big incoming towards downside

0 · Reply

ckjamesst Sep. 3 at 2:20 PM

$DXCM sell sell

0 · Reply

ckjamesst Sep. 3 at 2:14 PM

$DXCM insider selling you should sell

0 · Reply

ckjamesst Sep. 3 at 12:54 PM

$DXCM same pattern again and again…

0 · Reply

ckjamesst Sep. 3 at 12:46 PM

$DXCM it’s going to be volatile few months best time to get in puts

0 · Reply

LQQKER_INSIDER Sep. 2 at 6:16 PM

$DXCM I may, or may not have, taken a semi-aggressive bearish position in this stock today. 💋 Stock is a wee bit out ahead of its skis, imo. But I did love it in the $50's.

1 · Reply

LQQKER_INSIDER Sep. 2 at 12:26 PM

$DXCM Stock only $2.00 off 52-wk highs as we enter Sep, historically the absolute worst month for this stock. Only a 10% win rate in Sep over the past decade, and not a green one since 2021. For these reasons, I'm bearish at this moment in time.

0 · Reply

TheMarketsTheTarget Sep. 2 at 10:45 AM

$DXCM Solid company Not cheap Negative float though and making money with that fact. 👍🏼

0 · Reply

Kaythu Sep. 1 at 5:44 PM

$DXCM Potential!! This could be great! Start looking inot the acquisition of Modular Medical MODD. Their insulin patch pump looks very promising 🔥🔥🚀🚀

0 · Reply

ckjamesst Aug. 31 at 7:01 PM

$DXCM sell going back to 70-60

1 · Reply

ckjamesst Aug. 31 at 3:44 PM

$DXCM super bearish

0 · Reply

ckjamesst Aug. 31 at 3:35 PM

$DXCM it’s fked up how fked up these new investor are they don’t follow charts and get fked at the end take profit before too late

0 · Reply

ckjamesst Aug. 31 at 3:30 PM

$DXCM I was expecting 3-4% either side but idk

0 · Reply

ckjamesst Aug. 31 at 1:44 PM

$DXCM beautiful chart. To play with 92 to break upside and 88 for downside gl either we drop 4-5 or rise 4-5 today%

0 · Reply

ckjamesst Aug. 29 at 2:18 AM

$DXCM I genuinely think very overvalued competitors are taking dexcom market slowly specifically dealing with RFK. They pumping this stock for no reason I think it’s should be under 70 or even 60

0 · Reply

ckjamesst Aug. 29 at 1:06 AM

$DXCM big consolation is incoming in Dxcm gl

0 · Reply

ckjamesst Aug. 28 at 2:17 PM

$DXCM sold all my share so happy made decent profit and lost some oh well good luck

0 · Reply

Market Cap	31.33B
Revenue (ttm)	4.66B
Net Income (ttm)	836.30M
EPS (ttm)	N/A
PE Ratio	33.14
Forward PE	31.95
Profit Margin	17.94%
Debt to Equity Ratio	0.47

Volume	2,547,300
Avg Vol	4,605,830
Day's Range	N/A - N/A
Shares Out	377.36M
Stochastic %K	7%
Beta	1.42
Analysts	Strong Sell
Price Target	$92.89